A more consistent approach to asymptomatic PSA testing with initiatives to raise awareness about prostate cancer, communicating the pros and cons of undergoing PSA testing among men, and addressing barriers to accessing primary care may help to reduce such inequalities. This evidence concerns the gene KLK3 and prostate carcinoma.